1-3 of 3
Daniel J. DeAngelo, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of the Tyrosine Kinase Inhibitor PKC412 in Advanced Systemic Mastocytosis: Preliminary Results.

Jason Gotlib, MD, MS, Tracy I. George, M.D., Andrea Linder, R.N., Alisa Ruddell, R.N., Sylvia Quesada, R.N., Cem Akin, M.D., Daniel J. DeAngelo, M.D.,Ph.D., Pamela Cohen, M.D., Timothy Graubert, M.D.
Journal: Blood
Blood (2006) 108 (11): 3609.
https://doi.org/10.1182/blood.V108.11.3609.3609
Published: 2006
Journal Articles

PKC412 Inhibits the ZNF198-FGFR1 Fusion Tyrosine Kinase and Is Efficacious in Treatment of t(8;13)(p11;q12) Associated Stem Cell Myeloproliferative Disease.

Jing Chen, Ph.D., Daniel J. DeAngelo, M.D., Jeffery L. Kutok, M.D., Ph.D., Ifor R. Williams, M.D., Ph.D., Benjamin H. Lee, M.D., Ph.D., Martha Wadleigh, M.D., Nicole Duclos, Sarah Cohen, Jennifer Adelsperger, Rachel Okabe, Allison Coburn, Ilene Galinsky, Brian J.P. Huntly, M.D., Ph.D., Pamela Cohen, Ph.D., Thomas Meyer, Ph.D., Doriano Fabbro, Ph.D., Lolita Banerji, Ph.D., James D. Griffin, M.D., Sheng Xiao, M.D., Jonathan A. Fletcher, M.D., Richard M. Stone, M.D., D. Gary Gilliland, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2549.
https://doi.org/10.1182/blood.V104.11.2549.2549
Published: 2004
Journal Articles

Phase I Dose Escalating Trial of Bortezomib (Velcade®) in Combination with Idarubicin and Cytarabine in Patients with Acute Myeloid Leukemia.

Eyal C. Attar, M.D., Daniel J. DeAngelo, M.D., Ph.D., Karen K. Ballen, M.D., Emily Learner, Elizabeth G. Trehu, M.D., David P. Schenkein, M.D., James D. Levine, M.D., Richard M. Stone, M.D., Philip C. Amrein, M.D.
Journal: Blood
Blood (2004) 104 (11): 1799.
https://doi.org/10.1182/blood.V104.11.1799.1799
Published: 2004